Consultant Haematologist with interest in Myeloma

Facilities are available for all types of therapy including intensive chemotherapy, immunotherapy and both allogeneic (sibling, unrelated, umbilical cord blood, haploidentical) and autologous stem cell transplantation. RMH has a split site model with inpatient and outpatient care for haematology patients taking place across both sites. At RMH Sutton, inpatients are cared for in a dedicated facility on the second floor of the Sutton site.

• Provide medical leadership for myeloma patients undergoing outpatient and inpatient care at RMH Sutton.


• To take part in the teaching and training of doctors, nurses and other staff in myeloma management.


• To be involved in strategic development of myeloma T-cell directed therapy service for RMH.


• To contribute to academic research.


• To comply with trust policies on governance and to contribute to national, regional and local audits.


• To be an active member of the JACIE / HTA process and attend Quality meetings.


• To attend relevant MDTs.


• To participate actively in Continuing Professional Development and maintain a record of annual CPD, appraisals and revalidation as required by the GMC.


• On occasions to support / cover other consultant haematologists in the department and provide haematological advice to junior doctors and other RMH specialist staff (e.g. surgeons, oncologists).


• To participate in an on call rota (Sutton and Fulham road) frequency to be confirmed.
  
  The Royal Marsden is a world leader in cancer research, treatment and education. Together with our academic partner, The Institute of Cancer Research (ICR), we are the largest comprehensive cancer centre in Europe and the only National Institute of Health Research (NIHR) Biomedical Research Centre specialising in cancer in the UK.


Our mission is to continue to make a national and international contribution to cancer research and treatment, so that more people are cured and quality of life is improved for those with cancer. The Royal Marsden therefore plays an important role in championing change and improvement in cancer care through research and innovation, education and leading-edge treatment.

The Trust's annual budget is £360 million and we employ over 3,500 staff, including 335 medical staff, across two sites located in Chelsea and Sutton (Surrey). Over 50,000 patients attend The Royal Marsden each year. We provide community services across the Borough of Sutton. We have a Chemotherapy Medical Daycare Unit at Kingston Hospital.

We have a reputation for delivering high quality performance. We were ranked joint first in the CQC national inpatient survey results, above average in national cancer patient experience survey and ranked first amongst teaching hospitals in the UK for our staff survey results.